23andMe is a privately held personal genomics and biotechnology company based in Mountain View, California that claims to be developing new methods and technologies that will enable consumers to understand their own genetic information. The company is named for the 23 pairs of chromosomes in a normal human cell. The 23andMe website is currently split into four categories: Health and Traits, Ancestry, Sharing and Community, and Research. They currently test or are researching over 100 diseases, conditions, and traits. 23andMe was founded to "empower individuals and develop new ways of accelerating research." The initial cost of 23andMe's product was $999. In late 2010 23andMe introduced an alternative pricing option of $199 with a required one-year subscription of $5 a month, and in March 2011 $99 with $9/month (for at least one year). This subscription would provide subscribers with updates on discoveries made about their DNA over time. A single-fee payment of $399 without subscription is also available. Both Google and New Enterprise Associates have invested in 23andMe. Google has invested $3.9M and recently another $2.6M in 23andMe, whose co-founder Anne Wojcicki is married to
NEWS
Conversations
There are no new conversations. Be the first one.